About Vegea
Vegea is a company based in Rovereto (Italy) founded in 2016 by Gianpiero Tessitore, Valentina Longobardo, and Francesco Merlino.. Vegea offers products and services including VEGEA® and GrapeSkin®. Vegea operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Rovereto, Italy
- Founders Gianpiero Tessitore, Valentina Longobardo, Francesco Merlino
-
Sectors
RetailHealthcare Chemicals & Materials
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vegea Srl
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$618.61 K (USD), Grant
Aug 31, 2019
-
Investors
European Union
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vegea
Vegea offers a comprehensive portfolio of products and services, including VEGEA® and GrapeSkin®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Sustainable material from grape waste for fashion and packaging uses
Material derived from wine production waste for eco-friendly applications
Funding Insights of Vegea
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $618,605
-
First Round
First Round
(04 Jul 2017)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2019 | Amount | Grant - Vegea | Valuation |
investors |
|
| Jun, 2019 | Amount | Grant - Vegea | Valuation |
investors |
|
| Mar, 2018 | Amount | Grant - Vegea | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vegea
Vegea has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Chivas Venture and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startup accelerator
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vegea
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vegea
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vegea Comparisons
Competitors of Vegea
Vegea operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Vegea
When was Vegea founded?
Vegea was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Vegea located?
Vegea is headquartered in Rovereto, Italy. It is registered at Rovereto, Trentino-alto Adige, Italy.
Who is the current CEO of Vegea?
Gianpiero Tessitore is the current CEO of Vegea. They have also founded this company.
What does Vegea do?
Vegea is a biotechnology company that develops biomaterial from wine using bioprocess technology. The material is vegetal leather produced through a specific processing of fibers and vegetal oils contained in grape marc, which is a fully natural raw material consisting of the grape skins, stalks, and seeds obtained from winemaking. The product finds application in fashion design, in order to meet the need for green and animal-free products to be used in these Industries. As of July 2018, the company claims to derive 7 billion Kilograms of grape marc for an annual potential production of 3 billion square meters of Vegea.
Who are the top competitors of Vegea?
Vegea's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Vegea offer?
Vegea offers VEGEA® and GrapeSkin®.
Who are Vegea's investors?
Vegea has 4 investors. Key investors include European Union, Chivas Venture, EIC Fund, and UniCredit Start Lab.